Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
225M
-
Shares change
-
+17.4M
-
Total reported value, excl. options
-
$439M
-
Value change
-
+$34.6M
-
Put/Call ratio
-
0.1
-
Number of buys
-
121
-
Number of sells
-
-50
-
Price
-
$1.95
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q2 2025
206 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q2 2025.
Nuvation Bio Inc. - Common Stock (NUVB) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225M shares
of 339M outstanding shares and own 66.25% of the company stock.
Largest 10 shareholders include FMR LLC (51M shares), Decheng Capital LLC (26M shares), BlackRock, Inc. (25.7M shares), VANGUARD GROUP INC (15.9M shares), Omega Fund Management, LLC (11M shares), Laurion Capital Management LP (10.2M shares), Octagon Capital Advisors LP (7.69M shares), GEODE CAPITAL MANAGEMENT, LLC (5.99M shares), STATE STREET CORP (5.56M shares), and CITADEL ADVISORS LLC (5.53M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.